These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23569105)

  • 1. Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.
    Sinnecker D; Goedel A; Laugwitz KL; Moretti A
    Circ Res; 2013 Mar; 112(6):961-8. PubMed ID: 23569105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells in cardiovascular research.
    Sinnecker D; Dirschinger RJ; Goedel A; Moretti A; Lipp P; Laugwitz KL
    Rev Physiol Biochem Pharmacol; 2012; 163():1-26. PubMed ID: 22447279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
    Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.
    Sallam K; Li Y; Sager PT; Houser SR; Wu JC
    Circ Res; 2015 Jun; 116(12):1989-2004. PubMed ID: 26044252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?
    Knollmann BC
    Circ Res; 2013 Mar; 112(6):969-76; discussion 976. PubMed ID: 23569106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: is personalized medicine ready for prime time?
    Priori SG
    Circ Res; 2011 Sep; 109(8):822-4. PubMed ID: 21960720
    [No Abstract]   [Full Text] [Related]  

  • 8. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hawthorn ( Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia-specific induced pluripotent stem cells.
    Pahlavan S; Tousi MS; Ayyari M; Alirezalu A; Ansari H; Saric T; Baharvand H
    FASEB J; 2018 Mar; 32(3):1440-1451. PubMed ID: 29133340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Gepstein A; Arbel G; Caspi O; Miller L; Belhassen B; Nof E; Glikson M; Gepstein L
    J Am Coll Cardiol; 2012 Sep; 60(11):990-1000. PubMed ID: 22749309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 12. Modeling long-QT syndromes with iPS cells.
    Sinnecker D; Goedel A; Dorn T; Dirschinger RJ; Moretti A; Laugwitz KL
    J Cardiovasc Transl Res; 2013 Feb; 6(1):31-6. PubMed ID: 23076501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.
    Malan D; Friedrichs S; Fleischmann BK; Sasse P
    Circ Res; 2011 Sep; 109(8):841-7. PubMed ID: 21799153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias.
    Lu HR; Hortigon-Vinagre MP; Zamora V; Kopljar I; De Bondt A; Gallacher DJ; Smith G
    J Pharmacol Toxicol Methods; 2017 Sep; 87():53-67. PubMed ID: 28501647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.
    Song L; Awari DW; Han EY; Uche-Anya E; Park SH; Yabe YA; Chung WK; Yazawa M
    Stem Cells Transl Med; 2015 May; 4(5):468-75. PubMed ID: 25769651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.
    Kitaguchi T; Moriyama Y; Taniguchi T; Ojima A; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Morita M; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Tanaka K; Washio I; Miyamoto N
    J Pharmacol Toxicol Methods; 2016; 78():93-102. PubMed ID: 26657830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell technology and inherited arrhythmia syndromes.
    Ross SB; Fraser ST; Semsarian C
    Heart Rhythm; 2018 Jan; 15(1):137-144. PubMed ID: 28823602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
    Friedrichs S; Malan D; Sasse P
    Trends Cardiovasc Med; 2013 May; 23(4):91-8. PubMed ID: 23266156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New iPSC for old long QT syndrome modeling: putting the evidence into perspective.
    Li G; Cheng G; Wu J; Ma S; Sun C
    Exp Biol Med (Maywood); 2014 Feb; 239(2):131-40. PubMed ID: 24363251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
    Jæger KH; Wall S; Tveito A
    PLoS Comput Biol; 2021 Feb; 17(2):e1008089. PubMed ID: 33591962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.